1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novozymes A/S
  6. News
  7. Summary
    NZYM B   DK0060336014

NOVOZYMES A/S

(NZYM B)
  Report
Delayed Quote. Delayed Nasdaq Copenhagen - 05/25 10:59:40 am
425.9 DKK   -1.25%
05/23Transactions under Novozymes' stock buyback program
GL
05/16Transactions under Novozymes' stock buyback program
GL
05/16Transactions under Novozymes' stock buyback program
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Novozymes A/S : Univar Solutions Appointed as Distributor of Novozymes biological cleaning solutions in Brazil, Mexico, Paraguay, Uruguay and Bolivia

12/16/2021 | 03:49pm EDT

December 16, 2021 - Univar Solutions Inc. (NYSE: UNVR), a global chemical and ingredient distributor and provider of value-added services, today announced a new agreement with Novozymes, the world leader in biological solutions, expanding the partnership between the two companies into the homecare and industrial cleaning market for Brazil, Mexico, Paraguay, Uruguay and Bolivia. The exclusive agreement builds on existing partnerships between the two companies in Latin America, Europe and North America that helps provide customers with innovative enzyme and microbial solutions that improve cleaning product performance and lead to more sustainable products in the market.

"We are pleased that Novozymes continues to place their trust in Univar Solutions for five additional countries," said Jorge Buckup, president of Latin America for Univar Solutions. "Their portfolio of innovative enzyme solutions aligns with our purpose to help keep our communities healthy, fed, clean and safe. It is also in line with our desire to expand Univar Solutions' offering for the homecare and industrial cleaning market by partnering with a world-class manufacturer that has invested in global initiatives to safeguard our environment using strategies dedicated to innovation, quality and more sustainable solutions."

"Within the homecare and industrial cleaning market, consumer demand is trending toward more eco-friendly products that are designed to help conserve resources and minimize waste without compromising on safety, quality and performance," said Nick Powell, president of Industrial & Specialties for Univar Solutions. "The addition of Novozymes' biological cleaning products helps Univar Solutions increase its range of more sustainable solutions through a diverse set of quality ingredients for cleaners, detergents and disinfectant products."

"As Novozymes expands its offering of biological cleaning ingredients and sustainable solutions to regions around the world, we are excited to continue working with Univar Solutions as our new distributor in these five countries for the homecare and industrial cleaning market," says Arnaud Melin, Novozymes' Vice President of Consumer Biosolutions, Americas. "With Univar Solutions' dedicated industry team, supply chain expertise, and global network of innovative laboratories, together we are well-positioned to help customers develop innovative products that use raw materials more efficiently, reduce energy consumption and replace traditional chemicals with more sustainable alternatives."

For more information about biosolutions for the cleaning industry, please visit univarsolutions.com/cleaning-biosolutions.

About Univar Solutions Univar Solutions (NYSE: UNVR) is a leading global specialty chemical and ingredient distributor representing a premier portfolio from the world's leading producers. With the industry's largest private transportation fleet and technical sales force, unparalleled logistics know-how, deep market and regulatory knowledge, formulation and recipe development, and leading digital tools, the Company is well-positioned to offer tailored solutions and value-added services to a wide range of markets, industries, and applications. While fulfilling its purpose to help keep communities healthy, fed, clean and safe, Univar Solutions is committed to helping customers and suppliers innovate and focus on Growing Together. Learn more at univarsolutions.com.


Media Relations:
Frederik Bjoerndal, Novozymes North America | +1-646-671-3897 | TFBH@novozymes.com

Disclaimer

Novozymes A/S published this content on 16 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 December 2021 20:48:05 UTC.


© Publicnow 2021
All news about NOVOZYMES A/S
05/23Transactions under Novozymes' stock buyback program
GL
05/16Transactions under Novozymes' stock buyback program
GL
05/16Transactions under Novozymes' stock buyback program
GL
05/09Transactions under Novozymes' stock buyback program
GL
05/09Transactions under Novozymes' stock buyback program
GL
05/02Transactions under Novozymes' stock buyback program
GL
04/28NOVOZYMES A/S : Sowing seeds for future innovation in new plant science think tank
PU
04/27TRANSCRIPT : Novozymes A/S, Q1 2022 Earnings Call, Apr 27, 2022
CI
04/27NOVOZYMES A/S : 1st quarter report
CO
04/26Novozymes delivers strong 2022 Q1 results and raises full-year financial guidance
GL
More news
Analyst Recommendations on NOVOZYMES A/S
More recommendations
Financials
Sales 2022 16 844 M 2 426 M 2 426 M
Net income 2022 3 153 M 454 M 454 M
Net Debt 2022 5 434 M 783 M 783 M
P/E ratio 2022 37,4x
Yield 2022 1,35%
Capitalization 118 B 17 023 M 17 023 M
EV / Sales 2022 7,34x
EV / Sales 2023 7,08x
Nbr of Employees 6 641
Free-Float 72,6%
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | NZYM B | DK0060336014 | MarketScreener
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 425,90 DKK
Average target price 474,61 DKK
Spread / Average Target 11,4%
EPS Revisions
Managers and Directors
Ester Baiget President & Chief Executive Officer
Lars Green Chief Financial Officer & Executive Vice President
Jørgen Buhl Rasmussen Chairman
Claus Crone Fuglsang Chief Scientific Officer & Executive VP
Graziela Chaluppe dos Santos Malucelli Chief Operating Officer & Executive VP